AnalystsJeffrey HolfordJeffrey Holford's Stock Forecasts
AnalystsJeffrey Holford
Analyst Ranking
Top 44%
#2113 out of 4862 analysts
Average Return
+3.01%
Win Rate
60%3 out of 5
Risk vs Reward
Poor
Good
Jeffrey Holford's 5 best and worst ratings
Jeffrey Holford Analyst Color
Get additional color on Jeffrey Holford's coverage of popular stocks
Jeffrey Holford's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Parker Hannifin CorpPH | 1 | Strong Buy | $790.00 | +44.35% | Maintains | 3 months ago |
Astrazeneca PLCAZN | 1 | Hold | $42.00 | N/A | Assumes | 6 years ago |
Merck & Co IncMRK | 1 | Hold | N/A | N/A | Upgrades | 7 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $96.00 | N/A | Maintains | 8 years ago |
Abbvie IncABBV | 1 | Strong Buy | $107.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.